コメント (10)
トラックバックは利用できません。
A paradigm for how a single molecule can transform the management of a wide range of fungal diseases.
Loading doses are used in serious infections to achieve steady-state concentrations rapidly.
Diflucan serves as first-line for many non-severe Candida albicans infections.
Its cost-effectiveness is a significant advantage over newer, broader-spectrum azoles.
Diflucan is a model of predictable pharmacokinetics within the azole class.
Diflucan is not a substrate of the P-glycoprotein efflux pump, aiding its distribution.
Diflucan is used in some selective digestive decontamination protocols.
Hepatic metabolism becomes more significant in patients with end-stage renal disease.
Diflucan is a critical part of the antifungal arsenal in resource-limited settings.
In vitro synergy has been studied in combination with other agents like flucytosine.
A paradigm for how a single molecule can transform the management of a wide range of fungal diseases.
Loading doses are used in serious infections to achieve steady-state concentrations rapidly.
Diflucan serves as first-line for many non-severe Candida albicans infections.
Its cost-effectiveness is a significant advantage over newer, broader-spectrum azoles.
Diflucan is a model of predictable pharmacokinetics within the azole class.
Diflucan is not a substrate of the P-glycoprotein efflux pump, aiding its distribution.
Diflucan is used in some selective digestive decontamination protocols.
Hepatic metabolism becomes more significant in patients with end-stage renal disease.
Diflucan is a critical part of the antifungal arsenal in resource-limited settings.
In vitro synergy has been studied in combination with other agents like flucytosine.